These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25665656)

  • 1. Hierarchical clustering identifies a subgroup of colonic adenocarcinomas expressing crypt-like differentiation markers, associated with MSS status and better prognosis.
    Droy-Dupré L; Bossard C; Volteau C; Bezieau S; Laboisse CL; Mosnier JF
    Virchows Arch; 2015 Apr; 466(4):383-91. PubMed ID: 25665656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
    Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
    Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 6. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification].
    El Ayoubi A; Poizat F; Garrel R; Costes V; Guerrier B; Essakalli L; Kzadri M; Crampette L
    Ann Otolaryngol Chir Cervicofac; 2009 Sep; 126(4):175-81. PubMed ID: 19591973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
    Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
    Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
    Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II colon cancer.
    Cecchini MJ; Walsh JC; Parfitt J; Chakrabarti S; Correa RJ; MacKenzie MJ; Driman DK
    Hum Pathol; 2019 Aug; 90():70-79. PubMed ID: 31121192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study.
    Yousem SA
    Mod Pathol; 2005 Jun; 18(6):816-21. PubMed ID: 15605076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
    Landau MS; Kuan SF; Chiosea S; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.
    Kang H; An HJ; Song JY; Kim TH; Heo JH; Ahn DH; Kim G
    Histopathology; 2012 Oct; 61(4):576-86. PubMed ID: 22691042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
    Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
    World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Gastric Markers Is Associated with Malignant Potential of Nonampullary Duodenal Adenocarcinoma.
    Minatsuki C; Yamamichi N; Inada KI; Takahashi Y; Sakurai K; Shimamoto T; Tsuji Y; Shiogama K; Kodashima S; Sakaguchi Y; Niimi K; Ono S; Niwa T; Ohata K; Matsuhashi N; Ichinose M; Fujishiro M; Tsutsumi Y; Koike K
    Dig Dis Sci; 2018 Oct; 63(10):2617-2625. PubMed ID: 29956011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
    Bae JM; Lee TH; Cho NY; Kim TY; Kang GH
    World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.